Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 19/20 | 0.61 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.61 |
| ▸ | PIK3CG | P48736 | 11/20 | 0.61 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.61 |
| ▸ | PIK3R1 | P27986 | 10/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21174707 | 1.00 | PIK3CD (0.61) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL19646291 | 0.90 | PIK3CD (0.61) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL16630519 | 0.90 | PIK3CD (0.63) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL15812980 | 0.88 | PIK3CB (0.58) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL15812979 | 0.88 | PIK3CB (0.58) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL21174774 | 0.87 | PIK3CD (0.55) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL21174771 | 0.87 | PIK3CD (0.55) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL21174700 | 0.86 | PIK3CD (0.56) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL21174702 | 0.86 | PIK3CD (0.56) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 | |
| SCHEMBL21174802 | 0.86 | PIK3CD (0.50) | PIK3CDPIK3CBPIK3CGPIK3CAPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10751339-B2 | Substituted aminopyrimidine compounds and methods of use | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2020-08-25 | — | — | US | disclosed |
| US-20190224197-A1 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190224197-A1 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | PIK3CA, PIK3R1, PIK3R3 | PIK3CD 4/4885PIK3CB 9/4885PIK3CG 8/4885 |
| US-10751339-B2 | Substituted aminopyrimidine compounds and methods of use | PIK3CA, PIK3CD, MYD88 | PIK3CD 2/4885PIK3CB 4/4885PIK3CG 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.